Boxer Capital, LLC Sage Therapeutics, Inc. Transaction History

Boxer Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$25.95 - $43.15 $11.4 Million - $18.9 Million	-438,510 Reduced 28.61%	1,094,000 $45.5 Million
Q1 2020 May 15, 2020	BUY	$26.15 - $77.24 $30.9 Million - $91.3 Million	1,182,510 Added 337.86%	1,532,510 $44 Million
Q4 2019 Feb 14, 2020	BUY	$60.18 - $154.77 $21.1 Million - $54.2 Million	350,000 New	350,000 $25.3 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.